Breathe Well Live Well
Conditions: Allergy; Asthma; Rhinitis
Interventions: Drug: Mitizax; Drug: Placebo
Sponsors: Abbott; Linical Co., Ltd; Datamap
Recruiting – verified November 2015
View full post on ClinicalTrials.gov: asthma | received in the last 14 days
ChristianToday |
Asthma drug a potential treatment for aging brains, according to new study
ChristianToday A new study has found that a drug originally intended for the management of asthma attacks has been found to rejuvenate the aging brain. The study, conducted by researchers at Paracelsus Medical University in Austria and published in Nature … Affordable asthma medicine to treat dementia |
View full post on asthma – Google News
Herald Sun |
Australian researchers to test vaccine as asthma treatment in world-first trial
Herald Sun The trial, funded by Asthma Australia, will see 50 adults with eosinophilic asthma receive three doses of the vaccine over two months. “The strength is it is a completely new attack at approaching asthma. There is no other vaccine out there,” he said … |
View full post on asthma – Google News
|
Asthma Treatment Market: Fueling By – Increasing incidence of asthma cases …
Medgadget.com (blog) logo432 Asthma is a chronic inflammatory lung disease. Asthma affects personnel in all ages but mostly starts in childhood. Asthma creates inflammation in the inside walls of airways which makes airways very sensitive for the allergic reaction. Asthma … |
View full post on asthma – Google News
NDTV |
Unichem Gets USFDA Nod for Generic Asthma Treatment Tablets
NDTV New Delhi: Drug firm Unichem Laboratories has received approval from the US health regulator for its Montelukast Sodium tablets used in prevention and chronic treatment of asthma. "The company has received ANDA approval for Motelukast Sodium tablets … |
View full post on asthma – Google News
Medical Xpress |
Blanket approach to asthma treatment not ideal, researchers find
Medical Xpress Obstruction of the lumen of a bronchiole by mucoid exudate, goblet cell metaplasia, and epithelial basement membrane thickening in a person with asthma. Credit: Yale Rosen/Wikipedia/CC BY-SA 2.0. University of Queensland research into the effects of … |
View full post on asthma – Google News
| Related Articles |
Caregiver treatment satisfaction is improved together with children’s asthma control: Prospective study for budesonide monotherapy in school-aged children with uncontrolled asthma symptoms.
Allergol Int. 2015 Oct;64(4):371-6
Authors: Yoshihara S, Kanno N, Fukuda H, Arisaka O, Arita M, Sekine K, Yamaguchi K, Tsuchida A, Yamada Y, Watanabe T, Shimizu T, Nishikawa K, Nishimuta T
Abstract
BACKGROUND: If asthmatic children cannot obtain sufficient control of their disease, not only do they suffer from asthma symptoms, but the daily life activities of their caregivers are also disrupted. We investigated the effectiveness of an inhaled corticosteroid (ICS) for symptom control in previously ICS-untreated school-aged asthmatic children as well as caregiver treatment satisfaction (CTS).
METHODS: A multicenter, open-label, single-arm study on 12-week ICS (budesonide Turbuhaler(®)) monotherapy was undertaken in subjects aged 5-15 years with bronchial asthma not treated with ICS during the previous 3 months. At 0, 4, 8, and 12 weeks after start of ICS administration, Japanese Pediatric Asthma Control Program (JPAC) scores, and CTS scores were summated and lung function measured. At weeks 0 and 12, questionnaires on caregiver anxiety were also assessed.
RESULTS: Seventy-five patients were enrolled, and 69 assessed. Ninety percent of subjects had been treated with asthma controller medication except ICS before study enrollment. JPAC score and CTS score were improved significantly at weeks 4, 8, and 12 (p < 0.001). With regard to CTS, more than half of caregivers showed a perfect score at weeks 8 and 12. There was a significant correlation between JPAC score and CTS score. Lung function and caregiver anxiety were also improved, and good compliance with treatment was observed during the intervention.
CONCLUSIONS: If treating ICS-untreated school-aged asthmatic children with uncontrolled symptoms, ICS monotherapy can improve CTS along with improving asthma control.
PMID: 26433534 [PubMed – in process]
View full post on pubmed: asthma
Medical Daily |
Infants' Asthma Treatment May Cause Stunted Growth, But Breathing Is More …
Medical Daily A study presented over the weekend at the 54th annual meeting of the European Society for Pediatric Endocrinology in Spain suggests that asthma treatment in the first two years of a child's life may lead to stunted growth. However, because childhood … (+Video) Infants who get treated for asthma have stunted growth Asthma Drug Use in Infants Tied to Stunted Growth Asthma steroids 'could stunt growth' |
View full post on asthma – Google News
Nature World Report |
(+Video) Asthma treatment in babies under two stunts their growth
Nature World Report Researchers from Kuopio University Hospital and University of Eastern Finland analysed information on the height, weight and asthma medicine intake of 12,482 Finnish children aged 0-24 months. They found that children who used inhaled corticosteroids … Asthma steroids 'could stunt growth' Asthma medication for infants could lead to growth issues: Finnish Research Is your child taking asthma steroids? Researchers says Asthma medications … |
View full post on asthma – Google News
Nature World Report |
Asthma treatment in babies can affect their growth
Nature World Report Researchers from Kuopio University Hospital and University of Eastern Finland analysed information on the height, weight and asthma medicine intake of 12,482 Finnish children aged 0-24 months. They found that children who used inhaled corticosteroids … Asthma steroids 'could stunt growth' Asthma medication stunts growth among infants: Finnish Research Is your child taking asthma steroids? Researchers says Asthma medications … |
View full post on asthma – Google News